Fatal Sepsis in a Patient With Rheumatoid Arthritis Treated With Etanercept
- 1 June 2001
- journal article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 76 (6), 653-656
- https://doi.org/10.1016/s0025-6196(11)62418-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Unusual manifestations of invasive pneumococcal infectionAmerican Journal Of Medicine, 1999
- Extra-articular rheumatoid arthritis: prevalence and mortalityRheumatology, 1999
- Etanercept Therapy in Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- Anticytokine Therapy — A New Era in the Treatment of Rheumatoid Arthritis?New England Journal of Medicine, 1999
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999
- Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion ProteinNew England Journal of Medicine, 1996
- Streptococcal Infections of Skin and Soft TissuesNew England Journal of Medicine, 1996
- A case of necrotizing fasciitis due to Streptococcus pnewnoniaeBritish Journal of Dermatology, 1995